Keywords
nanoparticles
pharmacotherapy
How to Cite
Abstract
The article analyzes and summarizes the published data on the history of the use of silver particles of their known properties, as well as the prospects for the use of silver nanoparticles in different branches of medicine. The mechanism of action by which an antimicrobial effect is manifested silver particles. Data on the experimental and clinical studies based on silver nanoparticles. We also consider the various uses of nanosilver and possible negative consequences of its use.References
Благитко Е.М. Серебро в медицине / М.Е. Благитко, А.В. Бурмистов, А.П. Колесников и др. // Новосибирск: Наука-Центр, 2004. – 254 с.
Михиенкова А.И. Наночастицы серебра: характеристика и стабильность антимикробного действия коллоидных растворов / А.И. Михиенкова, Ю.П. Муха // Довкілля та здоров’я. – 2011. – № 1. – С. 55–59.
Synthesis and antibacterial properties of silver nanoparticles / C. Baker, A. Pradhan, L. Pakstis et al. // J. Nanosci Nanotechnol. – 2005. – Vol. 5, No. 2. – Р. 244–249.
Use of nanosilver in consumer products / K.W. Lem, A. Choundhury, A.A. Hakhani, et al. // J. Recent Pat Nanotechnol. – 2012. – Vol. 6, No. 1. – Р. 60–72.
Alexander J.W. History of the medical use of silver / J.W. Alexander // Surg. Infect. – 2009. – Vol. 10, No. 3. – Р. 289–292.
The progress of silver nanoparticles in the antibacterial mechanism, clinical application and cytotoxicity // C. You , C. Han, X. Wang, et al. // Mol. Biol. Rep. – 2012. – Vol. 39, No. 9. – Р. 9193–9201.
Braydich-Stolle L. Cytotoxicity of nanoparticles of silver in mammalian cells / L. Braydich-Stolle, S. Hussain, J. Schlager // Toxicological Sciences, 2005. – 380 p.
Soni I. Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria / I. Soni, B. Salopek-Bondi // J. Colloid Interface Sci. – 2004. – № 27. – P. 70–82.
Савченко Д.С. Изучение антиоксидантных свойств нанокомпозита высокодисперсного кремнезема с наночастицами серебра / Д.С. Савченко // Запорожский медицинский журнал. – 2012. – № 4 (73). – С. 124–128.
Stratchounski L.S. Antibiotic resistance in Russia / L.S. Stratchounski, O.U. Stetsiouk // Antibiotics Chemother. – 1997. – Vol. 1, No. 4. – Р. 8–9.
Williams J.D. Antibiotic resistance / J.D. Williams // Antibiotics Chemother. – 1998. – Vol. 2, No. 4. – P. 15–16.
Woraz K. Antimicrobial property of silver / K. Woraz // Toxicol. – 2001. – No. 12. – Р. 89–93.
Чекман И.С. Нанофармакология: экспериментально-клинический аспект / И.С. Чекман // Врач. дело. – 2008. – № 3–4. – С. 104–109.
An in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement / V. Alt, T. Bechert, P. Steinrücke et al. // Biomaterials. – 2004. – Vol. 25, No. 18. – P. 4383–4391.
Silver(I)-imidazole cyclophane gem-diol complexes encapsulated by electrospun tecophilic nanofibers: formation of nanosilver particles and antimicrobial activity / A. Melaiye, Z. Sun, K. Hindi et al. // J. Am. Chem. Soc. – 2005. – Vol. 127, No. 7. – Р. 2285–2291
Чекман І.С. Нанотехнології у розробці систем доставки лікарських засобів / І.С. Чекман, А.О. Прискока // Український мед. часопис. – 2010. – № 1 (75). – С. 14–18.